Literature DB >> 14733728

Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4.

Robert K Ernst1, Adeline M Hajjar, Jeff H Tsai, Samuel M Moskowitz, Christopher B Wilson, Samuel I Miller.   

Abstract

Lipid A is the pro-inflammatory component of bacterial lipopolysaccharide, the major surface component of Gram-negative bacteria. Gram-negative bacteria alter the structure of lipid A in response to specific environmental conditions including those found upon colonization of a host. The opportunistic pathogen Pseudomonas aeruginosa synthesizes a unique hexa-acylated lipid A containing palmitate and aminoarabinose during adaptation to the cystic fibrosis airway. Different lipid A species are observed in P. aeruginosa isolated from non-cystic fibrosis associated infections. Here we report that P. aeruginosa isolates from the airway of a cystic fibrosis patient with severe pulmonary disease synthesized a novel hepta-acylated lipid A. Cystic fibrosis-specific P. aeruginosa lipid A modifications result in resistance to host antimicrobial peptides and increased recognition by human Toll-like receptor 4 (TLR4). Using P. aeruginosa lipid A with different levels of acylation, we identified a 222 amino acid region in the extracellular portion of human TLR4 that is required for the differential recognition of cystic fibrosis-specific lipid A. P. aeruginosa adaptation to the human airway may, therefore, play a fundamental role in the progressive lung damage associated with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14733728     DOI: 10.1179/096805103225002764

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  38 in total

Review 1.  Innate immune responses to Pseudomonas aeruginosa infection.

Authors:  Elise G Lavoie; Tamding Wangdi; Barbara I Kazmierczak
Journal:  Microbes Infect       Date:  2011-08-02       Impact factor: 2.700

2.  Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia.

Authors:  Valerie J Waters; Marisa I Gómez; Grace Soong; Sunil Amin; Robert K Ernst; Alice Prince
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa.

Authors:  D K Augustin; Y Song; M S Baek; Y Sawa; G Singh; B Taylor; A Rubio-Mills; J L Flanagan; J P Wiener-Kronish; S V Lynch
Journal:  J Bacteriol       Date:  2007-01-05       Impact factor: 3.490

4.  Automated lipid A structure assignment from hierarchical tandem mass spectrometry data.

Authors:  Ying S Ting; Scott A Shaffer; Jace W Jones; Wailap V Ng; Robert K Ernst; David R Goodlett
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-05       Impact factor: 3.109

Review 5.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

6.  Role of pagL and lpxO in Bordetella bronchiseptica lipid A biosynthesis.

Authors:  I MacArthur; J W Jones; D R Goodlett; R K Ernst; A Preston
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

7.  Extracellular zinc induces phosphoethanolamine addition to Pseudomonas aeruginosa lipid A via the ColRS two-component system.

Authors:  Emily M Nowicki; John P O'Brien; Jennifer S Brodbelt; M Stephen Trent
Journal:  Mol Microbiol       Date:  2015-05-09       Impact factor: 3.501

Review 8.  Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.

Authors:  Christina K Lin; Barbara I Kazmierczak
Journal:  J Innate Immun       Date:  2017-02-22       Impact factor: 7.349

9.  Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It.

Authors:  Helen I Zgurskaya; Cesar A Löpez; S Gnanakaran
Journal:  ACS Infect Dis       Date:  2015       Impact factor: 5.084

10.  The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection.

Authors:  Samuel M Moskowitz; Robert K Ernst
Journal:  Subcell Biochem       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.